RIL
CRL icon

Rothschild Investment LLC’s Charles River Laboratories CRL Stock Holding History

Rothschild Investment LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Sell
153
-6
-4% -$1.07K ﹤0.01% 1341
2026
Q1 		$27.4K Sell
159
-32
-17% -$5.93K ﹤0.01% 1304
2025
Q4 		$38.1K Buy
191
+5
+3% +$907 ﹤0.01% 1110
2025
Q3 		$29.1K Buy
186
+84
+82% +$13.3K ﹤0.01% 1143
2025
Q2 		$15.5K Sell
102
-72
-41% -$9.6K ﹤0.01% 1086
2025
Q1 		$26.2K Buy
174
+144
+480% +$24.1K ﹤0.01% 927
2024
Q4 		$5.54K Buy
30
+14
+88% +$2.7K ﹤0.01% 1310
2024
Q3 		$3.15K Sell
16
-1
-6% -$208 ﹤0.01% 1481
2024
Q2 		$3.51K Buy
17
+6
+55% +$1.36K ﹤0.01% 1260
2024
Q1 		$2.98K Buy
11
+2
+22% +$478 ﹤0.01% 1181
2023
Q4 		$2.13K Buy
+9
New +$1.77K ﹤0.01% 1140
2020
Q4 		– Sell
-1,794
Closed -$407K – 459
2020
Q3 		$407K Buy
1,794
+464
+35% +$96.3K 0.04% 292
2020
Q2 		$232K Sell
1,330
-475
-26% -$75.8K 0.03% 358
2020
Q1 		$228K Buy
1,805
+126
+8% +$18.9K 0.03% 351
2019
Q4 		$256K Buy
+1,679
New +$232K 0.03% 386

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Rothschild Investment LLC's CRL Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Charles River Laboratories (CRL) stake by 3.8% in Q2 2026, selling an estimated $1.07K and leaving 153 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

Rothschild Investment LLC first reported a position in CRL in Q4 2019 and has held it in 15 quarters since. The position peaked at $407K in Q3 2020. 260 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Rothschild Investment LLC held 153 shares of Charles River Laboratories worth $34.7K as of Q2 2026.
  • Rothschild Investment LLC sold 6 Charles River Laboratories shares in Q2 2026, an estimated $1.07K.
  • Charles River Laboratories made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1341 holding.
  • Rothschild Investment LLC first reported a position in Charles River Laboratories in Q4 2019 and has held it in 15 quarters since.
  • Rothschild Investment LLC's Charles River Laboratories position peaked at $407K in Q3 2020.
  • 260 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.